WEKO3
アイテム
Updated Japanese Ministry of Health, Labour and Welfare Reimbursement Policy for Cardiac Positron Emission Tomography and Coronary Interventio
https://repo.qst.go.jp/records/49319
https://repo.qst.go.jp/records/4931904d161c1-4276-4e11-a7b2-a2ac2de169ad
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2018-09-18 | |||||
| タイトル | ||||||
| タイトル | Updated Japanese Ministry of Health, Labour and Welfare Reimbursement Policy for Cardiac Positron Emission Tomography and Coronary Interventio | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | journal article | |||||
| アクセス権 | ||||||
| アクセス権 | metadata only access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
| 著者 |
Yoshinaga, Keiichiro
× Yoshinaga, Keiichiro× Maruno, Hirotaka× Chikamori, Taishiro× Yoshinaga, Keiichiro |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | The Japanese Ministry of Health, Labour and Welfare (JMHLW) approved 13N-ammonia (13N-NH3) for detecting coronary artery disease (CAD) and 18F-fluorodeoxyglucose (18F-FDG) for cardiac sarcoidosis in 2012. These 2012 PET approvals shifted cardiac PET from research PET to clinical PET in Japan. Since the 2012 approvals, the nuclear cardiology community has realized the challenges of applying 13N-NH3 PET in clinical practice given the limited reimbursement through the health insurance system. Similar to the case with cardiac sarcoidosis, Japanese cardiologists have put great effort into treating patients with great arteritis such as Takayasu arteritis and have also shown the diagnostic utility of 18F-FDG PET/CT. Considering these issues, the Japanese Society of Nuclear Medicine (JSNM) and Japanese Circulation Society (JCS) worked together with JMHLW to update health insurance policy regarding PET. In addition, physiology-based coronary intervention has played an important role in the management of patients with CAD. Based on these recent developments and discussions with major societies, JMHLW released its updated reimbursement policy on March 5, 2018. This rapid communication will address the key issues of this policy update related to cardiovascular PET and coronary intervention. | |||||
| 書誌情報 |
Annals of Nuclear Cardiology 巻 4, 号 1, p. 42-45, 発行日 2018-08 |
|||||
| 出版者 | ||||||
| 出版者 | Shunkosha Co.,Ltd | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 2189-3926 | |||||
| DOI | ||||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | 10.17996/anc.18-00070 | |||||
| 関連サイト | ||||||
| 識別子タイプ | URI | |||||
| 関連識別子 | https://www.jstage.jst.go.jp/article/anc/4/1/4_18-00070/_article/-char/en | |||||
